Nohata Nijiro, Goto Yusuke, Gutkind J Silvio
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Department of Functional Genomics, Chiba University Graduate School of Medicine, Chiba, Japan.
J Hum Genet. 2017 Jan;62(1):87-96. doi: 10.1038/jhg.2016.124. Epub 2016 Oct 13.
The G-protein-coupled receptor (GPCR) family is the largest family of cell-surface receptors involved in signal transduction. Aberrant expression of GPCRs and G proteins are frequently associated with prevalent human diseases, including cancer. In fact, GPCRs represent the therapeutic targets of more than a quarter of the clinical drugs currently on the market. MiRNAs (miRNAs) are also aberrantly expressed in many human cancers, and they have significant roles in the initiation, development and metastasis of human malignancies. Recent studies have revealed that dysregulation of miRNAs and their target genes expression are associated with cancer progression. The emerging information suggests that miRNAs play an important role in the fine tuning of many signaling pathways, including GPCR signaling. We summarize our current knowledge of the individual functions of miRNAs regulated by GPCRs and GPCR signaling-associated molecules, and miRNAs that regulate the expression and activity of GPCRs, their endogenous ligands and their coupled heterotrimeric G proteins in human cancer.
G蛋白偶联受体(GPCR)家族是参与信号转导的最大的细胞表面受体家族。GPCR和G蛋白的异常表达常常与包括癌症在内的常见人类疾病相关。事实上,GPCR是目前市面上超过四分之一临床药物的治疗靶点。微小RNA(miRNA)在许多人类癌症中也异常表达,并且它们在人类恶性肿瘤的起始、发展和转移中发挥着重要作用。最近的研究表明,miRNA及其靶基因表达的失调与癌症进展相关。新出现的信息表明,miRNA在包括GPCR信号通路在内的许多信号通路的精细调节中发挥重要作用。我们总结了目前关于GPCR和GPCR信号相关分子调控的miRNA的个体功能,以及在人类癌症中调控GPCR、其内源配体及其偶联的异源三聚体G蛋白的表达和活性的miRNA的相关知识。